RVMD — Revolution Medicines Inc

Ownership history in Siren, L.L.C. · 6 quarters on record

This page tracks every 13F SEC filing in which Siren, L.L.C. reported a position in Revolution Medicines Inc (RVMD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position

3.17% (2025 Q4)

Avg. % of fund

1.8%

First filed

2024 Q3

Last filed

2025 Q4

Quarters held

6

Quarter	Action	Shares	Change	Chg %	% of Fund	Mkt Value	Price (EOQ)
2025 Q4	ADDED	1,335,075	+291,355	+27.9%	3.17%	$106.3M	$79.65
2025 Q3	ADDED	1,043,720	+104,965	+11.2%	1.91%	$48.7M	$46.70
2025 Q2	ADDED	938,755	+375,000	+66.5%	1.79%	$34.5M	$36.79
2025 Q1	REDUCED	563,755	-7,793	-1.4%	1.13%	$19.9M	$35.36

% of Fund (quarterly) RVMD price (monthly, adj. close)

Other funds also holding RVMD

As of 2025 Q4 — sorted by position size

AIHC Capital Management Ltd 67.21% Park Avenue Institutional Advisers LLC 3Y 7Y 40.5% Paradigm Biocapital Advisors LP 3Y 13.51% Casdin Capital, LLC 3Y 7Y 12.75% DAFNA Capital Management LLC 3Y 7Y 11.18% Alphabet Inc. 3Y 10.33% Logos Global Management LP 3Y 9.63% Checkpoint Capital L.P. 9.21% MIC Capital Management UK LLP 3Y 9.18% BVF INC/IL 3Y 7Y 9.0%

← Back to Siren, L.L.C. Holdings